Jw Life Science Corp (234080) - Total Liabilities

Latest as of June 2026: ₩79.02 Billion KRW ≈ $53.55 Million USD

Based on the latest financial reports, Jw Life Science Corp (234080) has total liabilities worth ₩79.02 Billion KRW (≈ $53.55 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore how much of Jw Life Science Corp's assets are long-term investments to see how much of total assets are deployed in long-term investments.

Jw Life Science Corp - Total Liabilities Trend (2015–2025)

This chart illustrates how Jw Life Science Corp's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Jw Life Science Corp (234080) total assets.

Jw Life Science Corp Competitors by Total Liabilities

The table below lists competitors of Jw Life Science Corp ranked by their total liabilities.

Company	Country	Total Liabilities
Singha Estate Public Company Limited BK:S	Thailand	฿49.24 Billion
AMREP Corporation NYSE:AXR	USA	$6.61 Million
GRP Limited NSE:GRPLTD	India	Rs2.83 Billion
Innate Pharma PA:IPH	France	€84.42 Million
Yieh Hsing Enterprise Co Ltd TW:2007	Taiwan	NT$8.22 Billion
Team Precision Public Company Limited BK:TEAM	Thailand	฿767.61 Million
Meiloon Industrial Co Ltd TW:2477	Taiwan	NT$4.29 Billion

Liability Composition Analysis (2015–2025)

This chart breaks down Jw Life Science Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Jw Life Science Corp net asset quality index to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.25	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.35	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.26	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Jw Life Science Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Jw Life Science Corp (2015–2025)

The table below shows the annual total liabilities of Jw Life Science Corp from 2015 to 2025.

Year	Total Liabilities	Change
2025-12-31	₩97.63 Billion ≈ $66.16 Million	-21.82%
2024-12-31	₩124.88 Billion ≈ $84.63 Million	+29.48%
2023-12-31	₩96.44 Billion ≈ $65.36 Million	-14.36%
2022-12-31	₩112.61 Billion ≈ $76.31 Million	+28.00%
2021-12-31	₩87.97 Billion ≈ $59.62 Million	+2.32%
2020-12-31	₩85.98 Billion ≈ $58.27 Million	+9.13%
2019-12-31	₩78.79 Billion ≈ $53.39 Million	-13.99%
2018-12-31	₩91.60 Billion ≈ $62.08 Million	-5.01%
2017-12-31	₩96.43 Billion ≈ $65.35 Million	-5.41%
2016-12-31	₩101.94 Billion ≈ $69.08 Million	+5.04%
2015-12-31	₩97.05 Billion ≈ $65.77 Million	--

About Jw Life Science Corp

KO:234080 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$115.22 Million

₩170.02 Billion KRW

Market Cap Rank

#18729 Global

#874 in Korea

Share Price

₩10980.00

Change (1 day)

+0.37%

52-Week Range

₩10720.00 - ₩15500.00

All Time High

₩26817.34